Related Experiment Video

Updated: Aug 17, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen: apparent 'masking' in original serum

P M Johnson

    Scandinavian Journal of Immunology
    |January 1, 1979
    PubMed

    Fourteen out of fifteen IgM-rheumatoid factor (IgM-RF) preparations isolated from high-titred seropositive rheumatoid sera by affinity chromatography on immobilized human IgG have been shown to cross-react with a cell nuclear antigen, as manifest by positive immunofluorescent anti-nuclear antibody (ANA) staining on rat liver and kidney tissue sections. The cross-reacting ANA activity within isolated IgM-RF preparations was inhibitable by both human and rabbit IgG, as well as by isolated rat liver chromatin, and could be isolated from seropositive ANA-negative sera. It would appear that this cross-reacting ANA activity can be masked in the original seropositive serum and may often require purification of RF from serum for its manifestation.

    More Related Videos

    Anti-Nuclear Antibody Screening Using HEp-2 Cells13:01

    Anti-Nuclear Antibody Screening Using HEp-2 Cells

    Published on: June 23, 2014

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis06:35

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

    Published on: February 8, 2019

    Related Concept Videos

    Cross-reactivity00:42

    Cross-reactivity

    Overview
    Hypersensitivity Reactions: Immune-Complex Reactions01:19

    Hypersensitivity Reactions: Immune-Complex Reactions

    Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...